Katherine was awarded a personal chair in health economics at The University of Manchester in August 2010. Katherine’s interest in the economics of precision medicine and genomics technologies and services started when she worked as the health economist for the North West Genetics Knowledge Park (Nowgen) between 2003 and 2007. In September 2007, Katherine was awarded a five-year Research Councils UK Academic Fellowship in Health Economics to focus on the evaluation and valuation of genomic technologies including genomic-based diagnostics and pharmacogenetic tests. Katherine was a member of a NICE Technology Appraisal Committee between October 2003 and 2012.
Katherine was awarded a personal Chair in Health Economics at The University of Manchester in August 2010. Katherine is also a registered pharmacist. Between 1990 and 1993, she worked as a hospital pharmacist and has since maintained links with the pharmacy profession to understand the training needs in health economics, in general, and the evaluation of genomic technologies specifically. She has extensive experience working as an academic health economist with different clinical research groups (eg. pharmacy, psychiatry, genetics). In 2007, Katherine joined the newly established Health Sciences - Methodology Group, which allowed her to develop applied and methodological grants. In 2007, she was awarded an RCUK Academic Fellowship to focus on the evaluation and valuation of genomic technologies including genomic-based diagnostics and pharmacogenetic tests. Based in the Manchester Centre for Health Economics, established in August 2012, she is now leading a research group that focuses on the evaluation and valuation of precision medicine and genomic technologies and services.